Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis

Thor D. Stein, Nicholas J. Anders, Charles DeCarli, Sic L. Chan, Mark P. Mattson, Jeffrey A. Johnson

Research output: Contribution to journalArticle

Abstract

Alzheimer's disease (AD) may be caused by the abnormal processing of the amyloid precursor protein (APP) and the accumulation of β-amyloid (Aβ). The amyloid precursor protein can be proteolytically cleaved into multiple fragments, many of which have distinct biological actions. Although a high level of Aβ can be toxic, the α-secretase cleaved APP (sAPPα) is neuroprotective. However, the mechanism of sAPPα protection is unknown. Here, we show that sAPPα increases the expression levels of several neuroprotective genes and protects organotypic hippocampal cultures from Aβ-induced tau phosphorylation and neuronal death. Antibody interference and small interfering RNA knock-down demonstrate that the sAPPα-driven expression of transthyretin and insulin-like growth factor 2 is necessary for protection against Aβ-induced neuronal death. Mice overexpressing mutant APP possess high levels of sAPPα and transthyretin and do not develop the tau phosphorylation or neuronal loss characteristic of human AD. Chronic infusion of an antibody against transthyretin into the hippocampus of mice overexpressing APP with the Swedish mutation (APP Sw) leads to increased Aβ, tau phosphorylation, and neuronal loss and apoptosis within the CA1 neuronal field. Therefore, the elevated expression of transthyretin is mediated by sAPPα and protects APP Sw mice from developing many of the neuropathologies observed in AD.

Original languageEnglish (US)
Pages (from-to)7707-7717
Number of pages11
JournalJournal of Neuroscience
Volume24
Issue number35
DOIs
StatePublished - Sep 1 2004
Externally publishedYes

Fingerprint

Amyloid Precursor Protein Secretases
Prealbumin
Amyloid beta-Protein Precursor
Neuroprotective Agents
Amyloid
Phosphorylation
Neurons
Alzheimer Disease
Antibodies
Poisons
Somatomedins
Mutant Proteins
Small Interfering RNA
Hippocampus
Apoptosis
Mutation
Genes

Keywords

  • α-secretase
  • β-amyloid
  • Alzheimer's disease
  • Neurodegeneration
  • Neuropathology
  • Neuroprotection
  • Neurotrophic
  • Organotypic slice culture

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons : Support for the amyloid hypothesis. / Stein, Thor D.; Anders, Nicholas J.; DeCarli, Charles; Chan, Sic L.; Mattson, Mark P.; Johnson, Jeffrey A.

In: Journal of Neuroscience, Vol. 24, No. 35, 01.09.2004, p. 7707-7717.

Research output: Contribution to journalArticle

@article{fe69878fd76946098242ccbee1d557d9,
title = "Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis",
abstract = "Alzheimer's disease (AD) may be caused by the abnormal processing of the amyloid precursor protein (APP) and the accumulation of β-amyloid (Aβ). The amyloid precursor protein can be proteolytically cleaved into multiple fragments, many of which have distinct biological actions. Although a high level of Aβ can be toxic, the α-secretase cleaved APP (sAPPα) is neuroprotective. However, the mechanism of sAPPα protection is unknown. Here, we show that sAPPα increases the expression levels of several neuroprotective genes and protects organotypic hippocampal cultures from Aβ-induced tau phosphorylation and neuronal death. Antibody interference and small interfering RNA knock-down demonstrate that the sAPPα-driven expression of transthyretin and insulin-like growth factor 2 is necessary for protection against Aβ-induced neuronal death. Mice overexpressing mutant APP possess high levels of sAPPα and transthyretin and do not develop the tau phosphorylation or neuronal loss characteristic of human AD. Chronic infusion of an antibody against transthyretin into the hippocampus of mice overexpressing APP with the Swedish mutation (APP Sw) leads to increased Aβ, tau phosphorylation, and neuronal loss and apoptosis within the CA1 neuronal field. Therefore, the elevated expression of transthyretin is mediated by sAPPα and protects APP Sw mice from developing many of the neuropathologies observed in AD.",
keywords = "α-secretase, β-amyloid, Alzheimer's disease, Neurodegeneration, Neuropathology, Neuroprotection, Neurotrophic, Organotypic slice culture",
author = "Stein, {Thor D.} and Anders, {Nicholas J.} and Charles DeCarli and Chan, {Sic L.} and Mattson, {Mark P.} and Johnson, {Jeffrey A.}",
year = "2004",
month = "9",
day = "1",
doi = "10.1523/JNEUROSCI.2211-04.2004",
language = "English (US)",
volume = "24",
pages = "7707--7717",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "35",

}

TY - JOUR

T1 - Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons

T2 - Support for the amyloid hypothesis

AU - Stein, Thor D.

AU - Anders, Nicholas J.

AU - DeCarli, Charles

AU - Chan, Sic L.

AU - Mattson, Mark P.

AU - Johnson, Jeffrey A.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Alzheimer's disease (AD) may be caused by the abnormal processing of the amyloid precursor protein (APP) and the accumulation of β-amyloid (Aβ). The amyloid precursor protein can be proteolytically cleaved into multiple fragments, many of which have distinct biological actions. Although a high level of Aβ can be toxic, the α-secretase cleaved APP (sAPPα) is neuroprotective. However, the mechanism of sAPPα protection is unknown. Here, we show that sAPPα increases the expression levels of several neuroprotective genes and protects organotypic hippocampal cultures from Aβ-induced tau phosphorylation and neuronal death. Antibody interference and small interfering RNA knock-down demonstrate that the sAPPα-driven expression of transthyretin and insulin-like growth factor 2 is necessary for protection against Aβ-induced neuronal death. Mice overexpressing mutant APP possess high levels of sAPPα and transthyretin and do not develop the tau phosphorylation or neuronal loss characteristic of human AD. Chronic infusion of an antibody against transthyretin into the hippocampus of mice overexpressing APP with the Swedish mutation (APP Sw) leads to increased Aβ, tau phosphorylation, and neuronal loss and apoptosis within the CA1 neuronal field. Therefore, the elevated expression of transthyretin is mediated by sAPPα and protects APP Sw mice from developing many of the neuropathologies observed in AD.

AB - Alzheimer's disease (AD) may be caused by the abnormal processing of the amyloid precursor protein (APP) and the accumulation of β-amyloid (Aβ). The amyloid precursor protein can be proteolytically cleaved into multiple fragments, many of which have distinct biological actions. Although a high level of Aβ can be toxic, the α-secretase cleaved APP (sAPPα) is neuroprotective. However, the mechanism of sAPPα protection is unknown. Here, we show that sAPPα increases the expression levels of several neuroprotective genes and protects organotypic hippocampal cultures from Aβ-induced tau phosphorylation and neuronal death. Antibody interference and small interfering RNA knock-down demonstrate that the sAPPα-driven expression of transthyretin and insulin-like growth factor 2 is necessary for protection against Aβ-induced neuronal death. Mice overexpressing mutant APP possess high levels of sAPPα and transthyretin and do not develop the tau phosphorylation or neuronal loss characteristic of human AD. Chronic infusion of an antibody against transthyretin into the hippocampus of mice overexpressing APP with the Swedish mutation (APP Sw) leads to increased Aβ, tau phosphorylation, and neuronal loss and apoptosis within the CA1 neuronal field. Therefore, the elevated expression of transthyretin is mediated by sAPPα and protects APP Sw mice from developing many of the neuropathologies observed in AD.

KW - α-secretase

KW - β-amyloid

KW - Alzheimer's disease

KW - Neurodegeneration

KW - Neuropathology

KW - Neuroprotection

KW - Neurotrophic

KW - Organotypic slice culture

UR - http://www.scopus.com/inward/record.url?scp=4444255624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444255624&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2211-04.2004

DO - 10.1523/JNEUROSCI.2211-04.2004

M3 - Article

C2 - 15342738

AN - SCOPUS:4444255624

VL - 24

SP - 7707

EP - 7717

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 35

ER -